Breaking Finance News

ValuEngine downgraded MEDNAX Inc (NYSE:MD) to Hold in a report released today.

ValuEngine has downgraded MEDNAX Inc (NYSE:MD) to Hold in a report released on Friday June 02, 2017.

Previously on 5/30/2017, Mizuho Securities reported about MEDNAX Inc (NYSE:MD) lowered the target price from $64.00 to $58.00. At the time, this indicated a possible upside of 0.06%.

Yesterday MEDNAX Inc (NYSE:MD) traded 0.00% even at $55.46. The company’s 50-day moving average is $42.97 and its 200-day moving average is $52.21. The last stock close price is up -14.74% from the 200-day moving average, compared to the S&P 500 which has increased 0.03% over the same time. 805,620 shares of the stock were exchanged, down from an average trading volume of 1,278,320

Performance Chart

MEDNAX Inc (NYSE:MD)

With a total market value of $0, MEDNAX Inc has price-earnings ratio of 14.18 with a one year low of $40.78 and a one year high of $72.13 .

A total of 11 analysts have released a report on MEDNAX Inc. Five analysts rating the company a strong buy, four analysts rating the company a buy, six analysts rating the company a hold, zero analysts rating the company a underperform, and finally zero analysts rating the company a sell with a 12-month price target of $77.64.

More About MEDNAX Inc (NYSE:MD)

MEDNAX, Inc. is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. As of December 31, 2016, the Company's national network consisted of over 3,600 affiliated physicians, including over 1,130 physicians providing neonatal clinical care, in 35 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. As of December 31, 2016, the Company had over 1,390 affiliated physicians providing anesthesia care to patients in connection with surgical and other procedures, as well as pain management. As of December 31, 2016, the Company had 270 affiliated physicians providing maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.